Literature DB >> 15099539

Gene expression profiling in MS: what is the clinical relevance?

Philip L De Jager1, David A Hafler.   

Abstract

Mesh：

Year:  2004        PMID： 15099539     DOI： 10.1016/S1474-4422(04)00731-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

1.  Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells.

Authors:  Philip L De Jager; Elizabeth Rossin; Saumyadipta Pyne; Pablo Tamayo; Linda Ottoboni; Vissia Viglietta; Mira Weiner; Dulce Soler; Elena Izmailova; Lauren Faron-Yowe; Carmeline O'Brien; Sam Freeman; Susana Granados; Alex Parker; Ronenn Roubenoff; Jill P Mesirov; Samia J Khoury; David A Hafler; Howard L Weiner
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

2.  Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?

Authors:  Naftali Kaminski; Anat Achiron
Journal:  PLoS Med       Date:  2005-02-22       Impact factor: 11.069

3.  Luteolin as a therapeutic option for multiple sclerosis.

Authors:  Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2009-10-13       Impact factor: 8.322
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.